Show simple item record

dc.creatorTchouaket Nguemeleu, Eric
dc.creatorBeogo, Idrissa
dc.creatorSia, Drissa
dc.creatorKilpatrick, Kelley
dc.creatorSéguin, Catherine
dc.creatorBaillot, Aurélie
dc.creatorJabbour, Mira
dc.creatorParisien, Natasha
dc.creatorRobins, Stephanie
dc.creatorBoivin, Sandra
dc.date.accessioned2020-07-24T22:17:40Z
dc.date.available2020-07-24T22:17:40Z
dc.date.created2020-07-08
dc.identifier.issn0195-6701spa
dc.identifier.otherhttps://www.sciencedirect.com/science/article/pii/S0195670120303327spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/11137
dc.format.extent42 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.publisherJournal of Hospital Infectioneng
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectRevisión sistemáticaspa
dc.subjectInfecciones nosocomialesspa
dc.titleEconomic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approachspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.subject.keywordSystematic reviewspa
dc.subject.keywordNosocomial infectionsspa
dc.subject.keywordHealthcare-associated infectionsspa
dc.subject.keywordPrevention and controlspa
dc.subject.keywordClinical best practicesspa
dc.subject.keywordEconomic evaluationspa
dc.subject.keywordRate of discountspa
dc.subject.keywordCost savingsspa
dc.subject.keywordIncremental benefit cost ratiospa
dc.identifier.doihttps://doi.org/10.1016/j.jhin.2020.07.004spa
dc.description.abstractenglishBackground Nosocomial or healthcare-associated infections (HCAIs) are associated with a financial burden that affects both patients and healthcare institutions worldwide. The clinical best care practices (CBPs) of hand hygiene, hygiene and sanitation, screening, and basic and additional precautions aim to reduce this burden. The COVID-19 pandemic has confirmed these four CBPs are critically important prevention practices that limit the spread of HCAIs. Aim This paper conducted a systematic review of economic evaluations related to these four CBPs using a discounting approach. Methods We searched for articles published between 2000 and 2019. We included economic evaluations of infection prevention and control of Clostridioides difficile-associated diarrhoea, meticillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and carbapenem-resistant Gram-negative bacilli. Results were analyzed with: cost-minimization, cost-effectiveness, cost-utility, cost-benefit and cost-consequence analyses. Articles were assessed for quality. Results A total of 11 898 articles were screened and seven were included. Most studies (4/7) were of overall moderate quality. All studies demonstrated cost effectiveness of CBPs. The average yearly net cost savings from the CBPs ranged from $252 847 (2019 $CAD) to $1 691 823 depending on the rate of discount (3% and 8%). The average incremental benefit cost ratio of CBPs varied from 2.48 to 7.66. Conclusion In order to make efficient use of resources and maximize health benefits, ongoing research in the economic evaluation of infection control should be carried out to support evidence-based healthcare policy decisions.spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record